Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO.
VA St. Louis Health Care System, St. Louis, MO.
Chest. 2022 Oct;162(4):920-929. doi: 10.1016/j.chest.2022.03.045. Epub 2022 Apr 8.
Prior studies in the civilian population have reported racial disparities in lung cancer outcomes following surgical treatment, including inferior quality of care and worse survival. It is unclear if racial disparities exist in the Veterans Health Administration (VHA), the largest integrated health care system in the United States.
Do racial disparities affect early-stage non-small cell lung cancer (NSCLC) outcomes following surgical treatment within the VHA?
This retrospective cohort study was conducted in veterans with clinical stage I NSCLC undergoing surgical treatment in the VHA system. Demographic characteristics, access to care, surgical quality measures, and short- and long-term oncologic outcomes between White and Black veterans were evaluated.
From 2006 to 2016, a total of 18,800 veterans with clinical stage I NSCLC were included. The rates of definitive surgical treatment were similar between Black (57.3%) and White (58.1%) veterans (P = .42). The final study cohort included 9,842 patients receiving surgical treatment, of whom 8,356 (84.9%) were White and 1,486 (15.1%) were Black. Black patients were younger and more likely to smoke, although comorbidities were similar between the two groups. Black patients were somewhat less likely to receive adequate lymph node sampling (30.6% vs 33.3%; P = .050); however, other access-to-care metrics and surgical quality measures, including rates of anatomic lobectomy (71.9% vs 69.4%; P = .189) and positive margins (3.2% vs 3.1%; P = .955), were similar between the two groups. Although Black veterans were less likely to experience major postoperative complications, there was no difference in 30-day readmission, 30-day mortality, or disease-free survival between the two groups. Black patients had significantly better risk-adjusted overall survival (hazard ratio, 0.802; 95% CI, 0.729-0.883; P < .001).
Among veterans with NSCLC undergoing surgical treatment through the VHA, Black patients received comparable care with equivalent if not superior outcomes compared with White patients.
先前的研究表明,在接受手术治疗的人群中,肺癌结局存在种族差异,包括医疗质量较差和生存率较低。在美国,退伍军人健康管理局(VHA)是最大的综合性医疗保健系统,尚不清楚是否存在种族差异。
VHA 系统中,接受手术治疗的早期非小细胞肺癌(NSCLC)患者的种族差异是否会影响其结局?
本回顾性队列研究纳入了在 VHA 系统中接受手术治疗的临床 I 期 NSCLC 退伍军人。评估了白人和黑人退伍军人之间的人口统计学特征、医疗服务可及性、手术质量指标以及短期和长期肿瘤学结局。
2006 年至 2016 年,共有 18800 名临床 I 期 NSCLC 退伍军人纳入研究。黑人(57.3%)和白人(58.1%)退伍军人接受确定性手术治疗的比例相似(P=0.42)。最终研究队列纳入 9842 例接受手术治疗的患者,其中 8356 例(84.9%)为白人,1486 例(15.1%)为黑人。黑人患者年龄较小且更可能吸烟,但两组的合并症相似。黑人患者接受充分的淋巴结采样的可能性略低(30.6%比 33.3%;P=0.050);然而,其他医疗服务可及性指标和手术质量指标,包括解剖性肺叶切除术的比例(71.9%比 69.4%;P=0.189)和阳性切缘的比例(3.2%比 3.1%;P=0.955),在两组之间相似。尽管黑人退伍军人术后发生重大并发症的可能性较低,但两组间 30 天再入院率、30 天死亡率或无病生存率无差异。调整风险后,黑人患者的总体生存率显著提高(风险比,0.802;95%置信区间,0.729-0.883;P<0.001)。
在 VHA 接受手术治疗的 NSCLC 退伍军人中,黑人患者获得了与白人患者相当甚至更好的治疗效果,尽管他们的医疗服务可及性存在差异。